T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report report published on Friday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Performance

Shares of TTOO stock opened at $0.11 on Friday. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80. The company has a 50 day moving average price of $0.13 and a 200 day moving average price of $0.50.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.